TY - JOUR T1 - A novel approach for assessing hypoperfusion in stroke using spatial independent component analysis of resting-state fMRI data JF - bioRxiv DO - 10.1101/2020.07.17.208058 SP - 2020.07.17.208058 AU - Jiun-Yiing Hu AU - Evgeniya Kirilina AU - Till Nierhaus AU - Smadar Ovadia-Caro AU - Michelle Livne AU - Kersten Villringer AU - Daniel Margulies AU - Jochen B. Fiebach AU - Arno Villringer AU - Ahmed A. Khalil Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/07/18/2020.07.17.208058.abstract N2 - Objective To identify, characterize, and automatically classify hypoperfusion-related changes in the blood oxygenation level dependent (BOLD) signal in acute stroke using spatial independent component analysis of resting-state functional MRI data.Methods We applied spatial independent component analysis to resting-state functional MRI data of 37 stroke patients scanned within 24 hours of symptom onset, 17 of whom received follow-up scans the next day. All patients also received dynamic susceptibility contrast MRI. After denoising and manually classifying the components, we extracted a set of temporal and spatial features from each independent component and used a generalized linear model to automatically identify components related to tissue hypoperfusion.Results Our analysis revealed “Hypoperfusion spatially-Independent Components” (HICs) whose BOLD signal spatial patterns resembled regions of delayed perfusion depicted by dynamic susceptibility contrast MRI. These HICs were detected even in the presence of excessive patient motion, and disappeared following successful tissue reperfusion. The unique spatial and temporal features of HICs allowed them to be distinguished with high accuracy from other components in a user-independent manner (AUC = 0.95, accuracy = 0.96, sensitivity = 1.00, specificity = 0.96).Interpretation Our study presents a new, non-invasive method for assessing blood flow in acute stroke that minimizes interpretative subjectivity and is robust to severe patient motion.Competing Interest StatementJ-Y.H., A.A.K., K.V., and J.B.F. are co-inventors of a method for automatically delineating perfusion lesions on perfusion MRI data (European Patent application 17179320.01-1906), distinct from the method described in this study, which is now in the public domain. J.B.F. reports grants from European Union 7th Framework Program and personal fees from Bioclinica, Artemida, Cerevast, Brainomix, BMS, Merck, Eisai, Biogen, Guerbet, and Nicolab outside the submitted work. ER -